The healthcare consulting industry in the DACH region includes firms that guide healthcare organizations through complex challenges, from regulatory compliance to operational efficiency. With a mix of experience and innovation, these companies provide insights on technology integrations, market strategies, and cost management. Stakeholders are increasingly focused on digital transformation and personalized medicine, emphasizing the growing importance of data in decision-making. Emerging health technologies, such as telemedicine and artificial intelligence, signal a transformative era, reshaping patient care and operational frameworks.


The list features a mix of 18 investors, including venture capitalists and corporate entities. Investors are headquartered across Germany, Austria, and Switzerland, with sizes ranging from small teams to large firms. Founded between 1979 and 2020, these firms made a notable 2024 deal count contributing to the healthcare sector, showcasing their commitment to innovation. Their strategic investments span various domains, emphasizing healthcare technology and consulting.


Top 18 Healthcare Consulting Investors in DACH


1. Novartis Venture Fund

  • Website: nvfund.com
  • Type: Venture Capital
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 11-50
  • Number of deals in 2024: 10

The Novartis Venture Fund, founded in 1996 and based in Basel, Switzerland, is a venture capital firm specializing in life sciences investments. With a focus on providing funding and support to innovative biotechnology and biopharmaceutical companies, the fund aims to help these businesses develop novel therapeutics and address unmet patient needs. Notable transactions include leading a $21.8 million Series C financing round for Ablation Frontiers, which is focused on clinical trials for medical devices, and a $18.52 million Series C investment in mPharma, a company working to improve access to essential medicines in Africa. Additionally, the fund participated in multiple funding rounds for FORMA Therapeutics, which raised significant capital to advance its therapeutic development. These investments highlight the fund's commitment to advancing healthcare solutions, making it a relevant player in the healthcare consulting space.


2. Novartis

  • Website: novartis.com
  • Type: Corporate
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 10001+
  • Number of deals in 2024: 7
  • LinkedIn: novartis

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company specializes in developing and manufacturing innovative medicines aimed at addressing serious diseases across various therapeutic areas. Novartis emphasizes research and development to enhance patient outcomes and has made several strategic investments in healthcare-related companies. Notably, they participated in the Series B funding of COTA Healthcare, which focuses on data analytics to improve cancer care, and Aspen RxHealth, which aims to revolutionize the pharmacy industry with its clinical pharmacy model. Additionally, Novartis has invested in Holmusk, a company that leverages data and technology to improve mental health outcomes. These transactions highlight Novartis's commitment to advancing healthcare services and consulting, making them a significant player in the healthcare consulting landscape.


3. Calm/Storm

  • Website: calmstorm.vc
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2020
  • Headcount: 1-10
  • Number of deals in 2024: 13
  • LinkedIn: calm-storm

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm specializes in early-stage investments in health tech startups, focusing on purpose-driven founders. They provide capital, support, and networking opportunities to help these companies succeed in the competitive health tech landscape. Their portfolio includes diverse teams addressing sensitive health issues. Notable transactions include OPEN Health, which raised $1.3 million in a Pre-Seed round, FemHealth Insights in a similar stage, and Foundation Health, which secured $6 million in a Seed round. These investments highlight Calm/Storm's commitment to fostering innovation in the healthcare consulting sector, particularly in health technology.


4. HBM Healthcare Investments AG


HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in the healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. In 2021, HBM co-invested in Swixx Biopharma, which raised close to €100 million to finance its growth, indicating HBM's active role in supporting companies that may require consulting services for strategic development and market entry. Additionally, HBM's involvement in Valo Health, which raised funds in a Series C round, further demonstrates their commitment to investing in innovative healthcare solutions. These transactions highlight HBM's engagement in the healthcare landscape, making them a potential player in the healthcare consulting space.


5. Bayern Kapital

  • Website: bayernkapital.de
  • Type: Venture Capital
  • Headquarters: Landshut, Bavaria, Germany
  • Founded year: 1995
  • Headcount: 11-50
  • Number of deals in 2024: 27
  • LinkedIn: bayern-kapital-gmbh

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria. They support their clients with financial resources and access to a network of industry experts, helping them navigate the challenges of growth and development in sectors such as life sciences and software. Notably, Bayern Kapital has been involved in several transactions relevant to the healthcare sector, including a seed financing round for Ebenbuild, a healthtech company developing a lung simulation prototype, and a Series A investment in NeoPrediX, which raised over $4 million for its healthcare innovations. Their portfolio also includes investments in companies like famPlus, which offers family support services, indicating a broader interest in health-related services.


6. Verve Ventures

  • Website: verve.vc
  • Type: Venture Capital
  • Headquarters: Zurich, Zurich, Switzerland
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 25
  • LinkedIn: investiere-venture-capital

Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their investment focus includes sectors such as climate tech, industrial technology, and health & bio, catering primarily to entrepreneurs and innovative companies seeking investment. Notably, Verve Ventures has been involved in several healthcare-related transactions, including DomoHealth, which raised funds in multiple rounds (Angel, Seed, and Series A) for its health technology solutions. More recently, they invested in Retinai, which raised significant amounts in Series A and Series B rounds in 2024, indicating a strong commitment to advancing healthcare technology and consulting solutions.


7. Sgs

  • Website: sgs.com
  • Type: Corporate
  • Headquarters: Geneva, Geneva, Switzerland
  • Founded year: 1878
  • Headcount: 10001+
  • Number of deals in 2024: 5
  • LinkedIn: sgs

SGS S.A. is a leading testing, inspection, and certification company founded in 1878, headquartered in Geneva, Switzerland. With a workforce of over 10,000 employees, SGS operates globally, providing independent services to ensure product quality and compliance across various industries. In recent years, SGS has made significant strides in the healthcare consulting sector through strategic acquisitions. Notably, in May 2023, SGS acquired a 60% stake in Nutrasource Pharmaceutical and Nutraceutical Services Inc., a global Contract Research Organization, which reported revenues of approximately CAD 20 million. This acquisition positions SGS to enhance its capabilities in pharmaceutical and nutraceutical consulting. Additionally, in July 2022, SGS acquired proderm GmbH, a provider of advanced clinical testing solutions for cosmetics and personal care products, further expanding its portfolio in clinical testing services relevant to healthcare. These transactions highlight SGS's commitment to enhancing its presence in the healthcare consulting industry, alongside its broader operations in testing and certification.


8. IBB Ventures


IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in early-stage financing and has invested in over 270 startups, providing not only funding but also expertise and resources to help these businesses thrive in competitive markets. Among their notable transactions, IBB Ventures invested in Famedly, a Berlin startup that raised EUR 2.5 million in seed financing to develop a digital data infrastructure for the healthcare sector. This investment highlights IBB Ventures' engagement in healthcare-related innovations. Additionally, they have participated in other seed rounds, such as Careloop, which raised over $2 million, indicating their active role in supporting startups that may have implications for healthcare consulting and services.


9. Partners Group

  • Website: partnersgroup.com
  • Type: Private Equity
  • Headquarters: Baar, Zug, Switzerland
  • Founded year: 1996
  • Headcount: 1001-5000
  • Number of deals in 2024: 19
  • LinkedIn: partners-group

Partners Group Holding AG is a prominent investment management firm based in Baar, Zug, Switzerland, specializing in private equity, private infrastructure, private real estate, and private debt. Founded in 1996, the firm manages over USD 149 billion in assets and offers a variety of investment solutions to institutional investors, private banks, and individual investors. Among their notable transactions, Partners Group acquired EyeCare Partners for $2.2 billion, showcasing their commitment to the healthcare sector. This integrated optometry-ophthalmology platform has experienced remarkable growth, with a compound annual growth rate (CAGR) of 65 percent under previous ownership. Additionally, their investments in companies like GlobalLogic and Version 1 highlight their strategic approach to growth and transformation across various sectors, including healthcare consulting.


10. Leaps by Bayer

  • Website: leaps.bayer.com
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2015
  • Headcount: 11-50
  • Number of deals in 2024: 16
  • LinkedIn: leapsbybayer

Leaps by Bayer is a venture capital firm based in Berlin, Germany, founded in 2015. It focuses on biotechnology and agriculture, investing in early-stage companies that pursue scientific breakthroughs to tackle significant global challenges in health and food security. In the healthcare sector, Leaps by Bayer has made notable investments, including a $90 million Series B investment in Ada Health, which develops AI-driven health assessment tools. They also participated in a $25 million Series A funding round for MedArrive, a company enhancing healthcare delivery through technology. Additionally, they invested in Transcarent, which raised $126 million in Series D funding, aimed at improving patient care. Their strategic investment in Woebot Health, a digital therapeutic for mental health, further emphasizes their commitment to innovative healthcare solutions.


11. Speedinvest

  • Website: speedinvest.com
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2011
  • Headcount: 51-200
  • Number of deals in 2024: 45
  • LinkedIn: speedinvest

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help these companies scale their operations. Speedinvest's investment focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Notably, they have also invested in healthcare-related startups, such as Elephant Healthcare, which raised $13.6 million in Series A funding, and Medicus AI, which received funding in an Angel Round. Additionally, they participated in funding rounds for Fertifa, a reproductive health startup, indicating their engagement in the healthcare consulting space. Their diverse portfolio and network of industry experts further enhance their ability to support healthcare innovations.


12. Debiopharm


Debiopharm is a biopharmaceutical company based in Lausanne, Switzerland, founded in 1979. The company specializes in the development and manufacturing of innovative therapies for cancer and infectious diseases, partnering with academic and pharmaceutical institutions to bridge the gap between drug discovery and patient access. In recent years, Debiopharm has made significant investments in healthcare technology companies that align with their mission to address unmet medical needs. Notable transactions include their participation in a €5.9 million capital increase for Voluntis, a leader in digital therapeutics, and a $15 million Series C funding round for BC Platforms, a genomic data management company. They also co-led a $6 million seed funding round for Altis Labs, which utilizes AI imaging biomarker technology for clinical trials, and participated in an $18 million Series C round for Carevive Systems, a company focused on software and analytics for healthcare providers. These investments highlight Debiopharm's commitment to advancing healthcare solutions and their relevance in the healthcare consulting space.


13. Wellington Partners


Wellington Partners is a Munich-based venture capital firm founded in 1998, specializing in life sciences. The firm invests in early- and growth-stage companies, providing both capital and strategic support to entrepreneurs in sectors such as therapeutics and medical devices. Notable transactions include a $55 million Series B investment in Sidekick Health, a digital therapeutics company, and a €4.5 million Seed Round for nyra health, which focuses on AI technology in healthcare. These investments highlight Wellington Partners' commitment to fostering innovative healthcare solutions and their active role in the healthcare consulting landscape.


14. Boehringer Ingelheim Venture Fund

  • Website: boehringer-ingelheim-venture.com
  • Type: Venture Capital
  • Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 5

Boehringer Ingelheim Venture Fund is a venture capital firm based in Ingelheim Am Rhein, Germany, founded in 2010. The fund specializes in investing in pioneering science and biotechnology innovations, particularly within the healthcare sector. They provide both capital and expertise to startups, helping them develop and commercialize their products. Notable transactions include a Series A funding round for Wellth, which raised $10 million to scale its healthcare solutions, and a Series A investment in xCures, which raised $12.69 million to enhance its AI-powered platform for precision oncology decision-making. Additionally, they co-led a Series B financing round for Brainomix, which focuses on developing AI-enabled platforms for better treatment outcomes in various therapeutic areas. These investments highlight their active role in supporting innovative healthcare solutions that may intersect with consulting services.


15. b2venture

  • Website: b2venture.vc
  • Type: Venture Capital
  • Headquarters: St. Gallen, St. Gallen, Switzerland
  • Founded year: 2000
  • Headcount: 11-50
  • Number of deals in 2024: 15
  • LinkedIn: btovpartners

b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. The firm specializes in early-stage investments across various sectors, including healthcare. They provide financial backing and strategic support to innovative startups, helping entrepreneurs navigate challenges and scale their businesses. Notably, b2venture has participated in significant transactions within the healthcare consulting context, such as their investment in Vamstar, a London-based provider of an AI-enabled procurement platform for medical supplies, which raised $9.5M in Series A funding. This platform aims to enhance data quality and digitize procurement processes in the healthcare industry. Additionally, b2venture was involved in the Series A funding of Retinai, a digital health startup that raised over $6.2M, further showcasing their commitment to healthcare innovation. Their collaboration with a community of angel investors enhances their investment strategy, positioning them as a key player in the European venture capital landscape, particularly in the healthcare sector.


16. Nextech Invest


Nextech Invest is a Zurich-based venture capital firm founded in 1998, specializing in biotechnology with a strong emphasis on cancer therapeutics. The firm invests in promising drug discovery companies and provides strategic support to help these firms navigate the complexities of drug development. Their clientele primarily consists of biotechnology companies seeking both financial backing and operational guidance. Notable transactions include a $77 million Series A financing for IconOVir Bio, aimed at developing oncolytic virus candidates for cancer treatment, and a $131.2 million Series C round for Cullinan Therapeutics, which focuses on innovative cancer therapies. In 2024, Nextech led a $150 million Series C round for Scorpion Therapeutics, further demonstrating their commitment to advancing cancer treatment solutions. These investments highlight Nextech's active role in the healthcare consulting space, particularly in supporting biotech firms through critical funding and strategic advice.


17. BiomedVC

  • Website: biomedvc.com
  • Type: Venture Capital
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 2003
  • Headcount: 1-10
  • Number of deals in 2024: 2
  • LinkedIn: biomedvc

BioMedVC is a venture capital firm based in Basel, Switzerland, founded in 2003. The firm specializes in early-stage investments in the life sciences sector, focusing on supporting biotech startups by providing capital and strategic guidance to help them develop innovative medical solutions. Notable transactions include their involvement with Miracor Medical, where they participated in multiple funding rounds (Series B, C, and D) to support the development of the PiCSO impulse system, a technology aimed at improving cardiac care. Additionally, they were involved in the Series A funding for Roche Glycart, which is significant in the context of advancing healthcare solutions. Their investments are primarily directed towards entrepreneurs and startups in the biotechnology industry, seeking to bring new health technologies to market, which aligns with the goals of healthcare consulting.


18. Bertelsmann Investments


Bertelsmann Investments is a venture capital firm based in Germany, founded in 2016. As part of the larger Bertelsmann group, which encompasses media, services, and education, the firm leverages its extensive portfolio and investment management capabilities to drive growth and innovation across various sectors. In the healthcare consulting context, Bertelsmann Investments has been involved in several notable transactions, including a seed funding round for Phare Health, which aims to develop innovative fintech tools for hospitals, and a Series B investment in Doccla, a company that provides digital healthcare solutions. Their participation in these funding rounds highlights their focus on healthcare innovation and consulting, aligning with their broader investment strategy.



Healthcare Consulting Insights: Key Investors in DACH


InvestorHeadquarterSizeFoundedDeals 2024
Novartis Venture FundBasel, Basel, Switzerland11-50199610
NovartisBasel, Basel, Switzerland10001+19967
Calm/StormVienna, Vienna, Austria1-10202013
HBM Healthcare Investments AGZug, Zug, Switzerland1001-500020018
Bayern KapitalLandshut, Bavaria, Germany11-50199527
Verve VenturesZurich, Zurich, Switzerland11-50201025
SgsGeneva, Geneva, Switzerland10001+18785
IBB VenturesBerlin, Berlin, Germany11-50199718
Partners GroupBaar, Zug, Switzerland1001-5000199619
Leaps by BayerBerlin, Berlin, Germany11-50201516
SpeedinvestVienna, Vienna, Austria51-200201145
DebiopharmLausanne, Vaud, Switzerland201-50019794
Wellington PartnersMunich, Bavaria, Germany11-5019989
Boehringer Ingelheim Venture FundIngelheim Am Rhein, Rhineland-Palatinate, Germany11-5020105
b2ventureSt. Gallen, St. Gallen, Switzerland11-50200015
Nextech InvestZurich, Zurich, Switzerland11-50199813
BiomedVCBasel, Basel, Switzerland1-1020032
Bertelsmann InvestmentsGermany11-5020166


Want to find more investors focusing on the healthcare consulting industry?

If you want to find more investors that are active in the healthcare consultingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!